3634 results for «267»

Filter By

3634 results

CTO PCI with Asian flavour

20 May 2025 – From EuroPCR 2025

Learn contemporary tips and tricks for chronic total occlusion (CTO) percutaneous coronary intervention (PCI) with an emphasis on specific algorithms to enhance procedural efficiency and safety. This session addresses overcoming obstacles in antegrade and retrograde approaches and managing potential complications through real-world case examples.

CTO PCI with Asian flavour

Novel tools and strategies for acute heart failure

20 May 2025 – From EuroPCR 2025

Explore novel mechanical circulatory support tools and strategies for acute heart failure management, including venoarterial ECMO with a customizable counter-pulsatile ventricular assist device, advanced Impella positioning techniques, mitral TEER for cardiogenic shock with mitral regurgitation, and the interplay between vasoactive and mechanical support in ischemic cardiogenic...

Novel tools and strategies for acute heart failure

My approach for a calcified bifurcation lesion

20 May 2025 – From EuroPCR 2025

This session provides a comprehensive approach to managing calcified bifurcation lesions. Learn how to interpret angiographic and intravascular imaging, plan interventions with appropriate devices for simplicity and safety, and evaluate final results to understand their clinical impact through real cases.

My approach for a calcified bifurcation lesion

Adressing complex anatomy in STEMI

20 May 2025 – From EuroPCR 2025

Address anatomical complexities in STEMI management through cases involving bilateral compromised coronary ostia due to aortic dissection, rare challenging STEMI presentations, coronary steal phenomena, diffuse atherosclerotic dissections in young patients, and aneurysmal coronary artery angioplasty in IgG4-related disease.

Adressing complex anatomy in STEMI

Challenging STEMI scenarios - Part 2

11 Dec 2025 – From GulfPCR-GIM 2025

This session presents complex STEMI cases that highlight the challenges of acute coronary syndrome management, including difficult arterial access, balancing reperfusion with embolization risks, and rare complications such as spontaneous coronary artery dissections. It emphasizes nuanced decision-making in high-stakes clinical scenarios.

Challenging STEMI scenarios - Part 2

Complex coronary complications

11 Dec 2025 – From GulfPCR-GIM 2025

This session addresses complex coronary complications through a series of challenging cases including dextrocardia with acute STEMI, fragile coronary anatomy risks, left main complications, and stent-related issues. It provides critical insights into recognizing and managing unexpected procedural challenges to improve patient safety.

Complication session

GulfPCR-GIM 2025 Opening Ceremony

10 Dec 2025 – From GulfPCR-GIM 2025

The GulfPCR-GIM 2025 Opening Ceremony marks the commencement of this prestigious cardiology congress, setting the tone for a comprehensive program dedicated to advancing interventional cardiology practice and research in the Gulf region and beyond.

GulfPCR-GIM 2025 Opening Ceremony

GulfPCR-GIM 2025 Closing Ceremony

11 Dec 2025 – From GulfPCR-GIM 2025

The GulfPCR-GIM 2025 Closing Ceremony marks the conclusion of an insightful and comprehensive congress, highlighting the latest advances and discussions in interventional cardiology. This session encapsulates the key takeaways and emerging themes that will shape future clinical practice and research in cardiology.

GulfPCR-GIM 2025 Closing Ceremony

Beyond the trial: how will SELUTION DeNovo redefine our PCI practice?

10 Dec 2025 – From GulfPCR-GIM 2025

This session looks beyond trial data to examine how the SELUTION DeNovo study may reshape PCI practice in real-world settings.

The discussion reviews key clinical results from this large-scale DeNovo PCI trial and explains the technology behind the SELUTION SLR drug-eluting balloon, including its slow-flow drug delivery...

Beyond the trial: how will SELUTION DeNovo redefine our PCI practice?

High bleeding risk and clinical outcomes in East Asian patients undergoing percutaneous coronary intervention: the PENDULUM registry

25 Feb 2021

The study aimed to evaluate the validity of the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria for East Asian patients undergoing contemporary percutaneous coronary intervention (PCI) from the PENDULUM registry.

Authors :

Masato Nakamura, Kazushige Kadota, Koichi Nakao, Yoshihisa Nakagawa, Junya Shite, Hiroyoshi Yokoi, Ken Kozuma, Kengo Tanabe, Raisuke Iijima, Atsushi Harada, Takeshi Kuroda, Yoshitaka Murakami
EuroIntervention: the PENDULUM registry

Impact of intravascular imaging guidance on percutaneous coronary intervention of severely calcified lesions: The ECLIPSE trial

29 Mar 2025

Aaysha Cader provides her take on the ECLIPSE trial presented by Gregg W. Stone at ACC.25 in Chicago.

Author

Aaysha Cader
Impact of intravascular imaging guidance on percutaneous coronary intervention of severely calcified lesions: The ECLIPSE trial

Early intra-aortic balloon pump in heart failure complicated by cardiogenic shock: The Altshock-2 randomized clinical trial

31 Mar 2025

Mirvat Alasnag provides her take on the Altshock-2 randomized clinical trial which was presented by Alice Sacco at ACC.25 in Chicago.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
Early intra-aortic balloon pump in heart failure complicated by cardiogenic shock: The Altshock-2 randomized clinical trial

BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial

07 Nov 2022

Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.

This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...

Nicola Ryan

Author

Nicola Ryan
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial

The JenaValve Trilogy™ heart valve system in high surgical risk patients with symptomatic, severe aortic regurgitation: The ALIGN AR Trial

25 Oct 2023

Nicola Ryan provides her take on the ALIGN AR trial which was presented by Vinod H. Thourani at TCT Congress 2023. The Align AR trial is a prospective single-arm investigation device exemption study assessing the safety and efficacy of the Trilogy transcatheter heart valve system in patients with...

Nicola Ryan

Author

Nicola Ryan
Initial Outcomes of the JenaValve Trilogy Transcatheter Aortic Valve Replacement System in High-Risk Patients with Symptomatic Severe Native Aortic Regurgitation (ALIGN-AR)
Didn’t find what you were looking for?